| Trial Name: |
Crohn's Disease
|
| Intro: |
This research study is designed to look at the safety and effectiveness of an oral study drug called AST-120 in participants who have Crohn's disease with a draining fistula |
| Condition: |
|
| Description: |
This research study is designed to look at the safety and effectiveness of an oral study drug called AST-120 in participants who have Crohn's disease with a draining fistula (an abnormal connection from one part of the intestine to another part of the intestine or the outside of the body). |
| Criteria: |
Participants must be between 18 and 65 years of age, must not have received infliximab within the past year and have a diagnosis of Crohn's disease with at least one draining fistula. |
| Contact: |
For information or to register for screening in this trial please call HealthMatch at (216) 844-5000, or complete and submit the form below. |
Participant Confidentiality:
All information regarding participation in Clinical Trials is treated with the
utmost confidentiality. University Hospitals Case Medical Center and the
Division of Clinical Research recognize and respect the confidentiality of this
information. Access to information related to clinical trials and their
participants is restricted to authorized clinical trials personnel only.
Back